Cabozantinib
Medication
Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine... Wikipedia
ATC code: L01EX07 (WHO)
ECHA InfoCard: 100.221.147
Elimination half-life: 110 hours
License data: US DailyMed: Cabozantinib
Other names: XL184, BMS907351, cabozantinib s-malate
Pregnancy category: : AU: D;
Visit The Official Physician Site To See Efficacy And Safety Data For LENVIMA Treatment. Discover More Information...
Find Information About CABOMETYX® At The Official Patient Website. Resources Available. Learn About A Co-pay...
Discover Info About This Treatment Option For Certain Patients With Advanced Kidney Cancer. FDA-Approved First-Line...